Raymon Pharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $15.7M

  • Investors
  • 10

Raymon Pharma General Information

Description

Developer and supplier of ophthalmic drugs. The company specializes in research and development of ophthalmic drugs and aims to provide innovative drugs to help patients resolve their illnesses.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 502, Building B2
  • No.218 Xinghu Street, Suzhou Industrial Park
  • Suzhou, Jiangsu
  • China
+86 155
Primary Industry
Pharmaceuticals
Corporate Office
  • Unit 502, Building B2
  • No.218 Xinghu Street, Suzhou Industrial Park
  • Suzhou, Jiangsu
  • China
+86 155

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Raymon Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 06-Apr-2022 $15.7M Completed Pre-Clinical Trials
3. Early Stage VC (Series A1) 15-Jun-2021 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 20-Nov-2020 Completed Pre-Clinical Trials
1. Seed Round 11-May-2018 Completed Startup
To view Raymon Pharma’s complete valuation and funding history, request access »

Raymon Pharma Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
CR Life Sciences Corporation Minority
Jinding Capital Venture Capital Minority
HM Capital Venture Capital Minority
Ascendin Fund Corporate Venture Capital Minority
Korea Investment Partners Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Raymon Pharma FAQs

  • When was Raymon Pharma founded?

    Raymon Pharma was founded in 2018.

  • Where is Raymon Pharma headquartered?

    Raymon Pharma is headquartered in Suzhou, China.

  • What industry is Raymon Pharma in?

    Raymon Pharma’s primary industry is Pharmaceuticals.

  • Is Raymon Pharma a private or public company?

    Raymon Pharma is a Private company.

  • What is Raymon Pharma’s current revenue?

    The current revenue for Raymon Pharma is .

  • How much funding has Raymon Pharma raised over time?

    Raymon Pharma has raised $31.3M.

  • Who are Raymon Pharma’s investors?

    CR Life Sciences, Jinding Capital, HM Capital, Ascendin Fund, and Korea Investment Partners are 5 of 10 investors who have invested in Raymon Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process